On Thursday, in the course of current trade, Shares of Ford Motor Co. (NYSE:F), dropped -0.23%, and is now trading at $15.29.
Ford Motor Company, is offering competitors access to its electrified vehicle technology patents – a move to assist accelerate industry-wide research and development of electrified vehicles.
In 2014, Ford filed more than 400 patents dedicated to electrified vehicle technologies. This is more than 20 percent of the patents the company filed – totaling more than 2,000 applications.
Ford Motor Company is a leader in this area – offering six hybrid or fully electrified vehicles counting Ford Focus Electric, Ford Fusion Hybrid, Ford Fusion Energi plug-in hybrid, Ford C-MAX Hybrid, Ford C-MAX Energi plug-in hybrid and Lincoln MKZ Hybrid. In total, Ford has more than 650 electrified vehicle patents and about 1,000 pending patent applications on electrified vehicle technologies.
Ford Motor Company manufactures and distributes automobiles worldwide. The company operates through two sectors, Automotive and Financial Services. The Automotive sector develops, manufactures, distributes, and services vehicles, parts, and accessories.
During Morning trade, Shares of SeaDrill Limited (NYSE:SDRL), dipped -5.18%, and is now trading at $12.07.
Seadrill Ltd. fell in Oslo trading as the offshore driller controlled by billionaire John Fredriksen sees the rig market remaining challenging until next year after a collapse in oil prices, according to Bloomberg.
“The industry continues to face challenging times and while the first quarter performance has been solid we are not immune,” Chief Executive Officer Per Wullf said in the company’s first-quarter report. “Indications suggest the remainder of 2015 will see subdued market conditions and the challenging market ongoing into 2016.”
Seadrill shares fell even as it posted first-quarter net income of $427 million as it cut costs. That beat a $320 million average estimate in a Bloomberg survey of 12 analysts. Bloomberg Reports.
Seadrill Limited, an offshore drilling contractor, provides offshore drilling services to the oil and gas industry worldwide. The company operates through Floaters and Jack-up Rigs segments.
Shares of Merck & Co. Inc. (NYSE:MRK), during its Thursday’s current trading session gained 0.35%, and is now trading at $59.67.
Merck, declared the global partnership agreement with the fertility technologies expert Genea Biomedx, an Australian company, dedicated to advancing fertility science and assisting couples create families. With this partnership, Merck Serono, the biopharmaceutical business of Merck, and global market leader in drugs for Assisted Reproductive Treatment (ART), receives global marketing and commercialization rights to Genea Biomedx’s product portfolio. This comprises the innovative Gavi, Geri and Gems product lines which are predictable to receive CE mark in Europe shortly, in addition to a joint development pipeline.
Gavi will be the world’s first fully automated vitrification instrument, focusing on lab processes with the aim of reducing potential errors and increasing efficiency in cryopreservation of embryos and in the future for oocytes (eggs). Geri is a benchtop incubator fitted with a time-lapse camera to capture images of embryos as they develop and individually controlled incubation chambers per patient to minimize disruptive events to the early-stage embryo. Gems is the latest generation of Genea’s culture media allowing for high quality embryo cultivation.
The partnership is part of the company’s strategy to provide the best fertility solutions to its customers to enhance success rates. With the global rights to these three product lines and future developments, Merck Serono is expanding its market position, offering key potentially outcome improving technologies to support standardization, automation and objectivity. To further strengthen this position, Merck Serono will closely collaborate with Genea Biomedx to jointly develop other innovative technology products and services, and have formed a development hub to pave the way for further improvements for the patient.
Merck & Co., Inc. provides health care solutions worldwide. The company offer therapeutic and preventive agents to treat cardiovascular, type 2 diabetes, asthma, nasal allergy symptoms, allergic rhinitis, chronic hepatitis C virus, HIV-1 infection, fungal infections, intra-abdominal infections, hypertension, arthritis and pain, inflammatory, osteoporosis, male pattern hair loss, and fertility diseases.
Finally, Cypress Semiconductor Corporation (NASDAQ:CY), gained 0.72% Thursday.
ZTE, a leading global provider of telecommunications equipment, network solutions and mobile devices, has selected a TrueTouch® capacitive touchscreen controller from Cypress Semiconductor Corp. for its flagship nubia Z7 Max smartphone. The phone uses the TrueTouch TMA568 controller to implement an easy-wake gesture feature that enables the user to wake the phone’s screen from sleep-mode by simply double tapping on the screen with a finger.
The nubia Z7 Max comprises a 5.5-inch full HD touchscreen with robust water tolerance driven by the TMA568 controller. The controller brings the market’s most accurate gloved finger tracking to the phone and the ability to automatically switch between glove and finger tracking without requiring the user to change the phone’s settings. Additionally, TrueTouch controllers deliver the world’s highest immunity to electrical noise from chargers and displays, delivering reliable touch input in real-world environments where competing solutions experience false and missed touches.
Cypress Semiconductor Corporation provides mixed-signal programmable solutions, specialized semiconductor memories, and integrated semiconductor solutions worldwide. The companys Memory Products division designs and manufactures static random access memory (SRAM) products and nonvolatile RAMs used to store and retrieve data in networking, wireless infrastructure and handsets, computation, consumer, automotive, industrial, and other electronic systems; and general-purpose programmable clocks.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
